Drugs / ertugliflozine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06983054 Comparator | Jul 2023 → Dec 2025 overdue | type 2 diabetes mellitus | Amsterdam UMC, location VUmc | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ertugliflozine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06983054 ↗ |